PROGRAM AT GLANCE

APASL BNDCC Bali, 4-8 March 2020

Time Wednesday, 04 March 2020 Thursday, 05 March 2020 Friday, 06 March 2020 Saturday, 07 March 2020

Re-Registration & On Site Including Morning Coffee Break (Jimbaran

Re-Registration & On Site Re-Registration & On Site Re-Registration & On Site
07.00-16.00 Lobby)
07.30-08.00
S1
08.00-08.30 Clinical Dilemma in S2
Hepatitis B Virus Autoimmune Liver
WS 1 Session I Infection and Liver Diseases: An
S6 S8 S 12
& II APASL-AEG WS 4 Transplantation Update S7 S 13
Pediatric Hepatitis Virus Presidential Plenary S 14
Workshop WS 2 WS 3 Workshop in (Nusa Dua (Nusa Dua Hall 4) Perspective in Critical care in
Hepatology Infection and The (Best Abstract) Update on HCC (Nusa Dua
Frontiers Endoscopy Session I Session I APASL- Challenges in Liver Hall 1,2,3) NAFLD in Asia Hepatology
(Nusa Dua Hall Others (Nusa Dua Hall 1,2,3) Hall 5)
in Liver Disease Intervention in AASLD Research Transplantation and (Nusa Dua Hall 4) (Nusa Dua Hall 4)
08.30-09.00 (Nusa Dua Hall 1) Hepatobiliary (Nusa Clinical Workshop Current Surgical 1,2,3) (Nusa Dua Hall 5)
Dua Hall 2) (Nusa Dua Hall 3) Innovation (Uluwatu
Hall 1) PRESIDENTIAL LECTURE
(Nusa Dua Hall 5)
09.00-09.30
Coffee Break Coffee Break
09.30-10.00 (Inside The Room) (Inside The Room)
Coffee Break
10.00-10.30 (Inside The Room) S9 S 15
S 16
WS 5 SIG 2 Liver New Issues on Liver Cirrhosis: New S 17
Women in
10.30-11.00 Session I Post Opening Ceremony + Award Lecture Fibrosis (Nusa Dua Hepatocellular Issue on Stem Cell in Liver Diseases
WS 2 Session Hepatology (Nusa
WS 1 Session WS 3 Graduate Course Hall 1,2,3) Carcinoma (Nusa management (Nusa (Nusa Dua Hall 5)
II (Nusa Dua Dua Hall 4)
III APASL-AEG Session II APASL- All About Portal Dua Hall 4) Dua Hall 1,2,3)
11.00-11.30 Phantom Hands On Hall 5)
(Batch 1) Phantom AASLD Research Hypertension
Workshop (RFA)
Hands On Workshop Clinical Workshop (Nusa Dua Hall 4)
(Nusa Dua Hall State of The Art Lecture 3
(Nusa Dua Hall 1) (Nusa Dua Hall 3)
2) (Nusa Dua Hall 1,2,3) LUNCH
(SINGARAJA HALLS)
11.30-12.00
12.00-12.30
LUNCH
(Singaraja Hall) LUNCH
12.30-13.00 LUNCH (Singaraja Halls)
(SINGARAJA HALLS)
FRIDAY PRAYER (Kintamani Hall 1)
Industrial Symposium
4
13.00-13.30 by MYLAN
WS 3
WS 5 Industrial Symposium 1 (Nusa Dua Hall 1,2,3)
Poster Viewing & Oral
WS 1 Session Session II Post by EISAI
Abstract
III APASL-AEG Graduate Course (Nusa Dua Hall 1,2,3) S 10
13.30-14.00 Presentations S 11
(Batch 2) Phantom All About Portal General Hepatology
APASL-AASLD Update on Biliary
Hands On Workshop Hypertension Update Symposium
14.00-14.30 Clinical Research Diseases (Nusa
(Nusa Dua Hall 1) (Nusa Dua Hall 4) (Nusa Dua Hall S 18 S 19
Workshop Dua Hall 4)
(Nusa Dua Hall 3) State of The Art Lecture 1 1,2,3) NAFLD and Other Infection in APASL - EASL
(Nusa Dua Hall 5) Related Problems Hepatobilliary Joint Meeting
14.30-15.00 (Nusa Dua Diseases (Uluwatu Hall 7)
Coffee Break (Inside WS 3 Panel Coffee Break (Inside Hall 1,2,3) (Nusa Dua Hall 4)
15.00-15.30 The Room) Session The Room)
APASL-AASLD WS 5 SIG I S3
Research Session III Post Palliative Care in Clinical Dilemma Coffee Break
Methodology Graduate Course Hepato-Pancreato and Innovation in (Inside The Room)
15.30-16.00 (Nusa Dua Hall 3) All About Portal Biliary Disorders HCC Therapy
Hypertension (Nusa (Nusa Dua (Nusa Dua Hall
Dua Hall 4) Hall 4) 1,2,3)
S 22
16.00-16.30 Coffee Break S 20 S 21 Regression of Fibrosis and
Heart and Liver Lung and Liver Portal Hypertension in CLD:
(Nusa Dua Hall 1,2,3) (Nusa Dua Hall 4) Is It Really Feasible?
16.30-17.00
(Inside The Room) (Uluwatu Hall 7)

17.00-17.30 S4
S5
Coagulation
Ultrasound
Disorders and
Innovation and
Hypersplenism and
Cutting Edge in
in Liver Disease
HCC
17.30-18.00 (Nusa Dua
(Nusa Dua Hall 5)
Hall 4)
18.00-18.30 GALA DINNER, AWARD PRESENTATION
Faculty Dinner
Sponsored Symposium Dinner ( MINOPHAGEN - DEXA MEDICA) & CLOSING CEREMONY
Faculty Dinner (Negara Room, Grand Hyatt Hotel)
(Nusa (Nusa Dua Hall 5)
18.30-20.00 (WESTIN TEMPLE GARDEN)
Dua Hall 1,2,3)
ORAL PRESENTATION SESSION
5, 6, 7th March 2020

Time Thursday, 05th March 2020

Session 1 10.00-
12.00 WITA

10.00-10.10
10.10-10.20
10.20-10.30
10.30-10.40
10.40-10.50
10.50-11.00
11.00-11.10
 Friday, 06 March 2020 Satur
Mengwi 2 Room Chairman: Mengwi 3 Room
Mengwi 5 Room Chairman: Mengwi 2 Room
CH Liu, Taiwan Chairman: Ian Homer Y.Cua, Philippines
Khin Maung Win, Myanmar Chairman: Anna Lok, USA Co-
Co-Chair: Agus Sudiro Waspodo, Indonesia Co-Chair: FX. Pridady,
Co-Chair: Grace Wong, HongKong Chair: Ming Lung Yu, Taiwan
Indonesia
 Saturday, 07th March 2020
Mengwi 3 Room Chairman: Mengwi 5 Room Chairman:
Laurent Castera, France Co- Necati Ormeci, Turkey Co-
Chair: Lukman Hakim, Indonesia Chair: Vincent Ho, Australia
Tentative Scientific Schedule
APASL 2020 - 4-8 March 2020 - BNDCC , Nusa Dua, Bali, Indonesia

Wednesday, 4 March 2020

08.00 -16.00 Re-registration & On site

Workshop 1 - Nusa Dua Hall 1 Workshop 2 - Nusa Dua Hall 2 Workshop 3 - Nusa Dua Hall 3 WS 4 - Workshop on Challenges in Liver Transplantation and Current Surgical Innovation in
Asian EUS Group (AEG) Workshop - APASL Endoscopy Course Intervention in Hepatobiliary APASL-AASLD Clinical Research Workshop Hepatobilliary Disorders (Uluwatu Hall 1)
08.00-12.00 08.00-12.10 08.00-10.00
08.00-08.55 Session I Frontiers Endoscopy in Liver Disease - Nusa Dua Hall 1 Course Director: Shuichiro Shiina, Japan Workshop Director : W Ray Kim, USA Chairman : Mureo Kasahara, Japan
Chairman : Kazuo Hara, Japan Juferdy Kurniawan, Indonesia Rino A. Gani, Indonesia Co Chair : Wifanto S. Jeo, Indonesia
Co-Chair : Ari Fahrial Syam, Indonesia 08.00-08.05 Introduction Comprehensive Aspects in Living Donor Liver Transplantation
08.00-08.25
Endoscopic polypectomy in patients with advanced liver disease Rino A. Gani, Indonesia Toar J.M. Lalisang, Indonesia
08.00-08.15
Marcellus Simadibrata, Indonesia RFA Basic Procedure Equipment and Preparation 08.05-08.30 Spectrum of Clinical Research Surgical Approach in Large Primary Liver Tumor
08.00-08.20 08.25-08.50
ERCP in Advance Liver Cirrhosis Juferdy Kurniawan, Indonesia W. Ray Kim, USA Wifanto S. Jeo, Indonesia
08.15-08.30 RFA in Liver Malignancies: Tips & Trick in Various
Begawan Bestari, Indonesia Setting Up Multicenter Studies Surgery in Metastatic Liver Tumor Non-Colorectal Cancer
08.20-09.00 Circumtances 08.30-08.55 08.50-09.15
ERCP and Cholangioscopy in Hepatobiliary Diseases Shuichiro Shiina, Japan Jasmohan Bajaj, USA Adianto Nugroho, Indonesia
08.30-08.45 RFA vs Microwave : Which is Better in liver
Ari Fahrial Syam, Indonesia Pediatric Liver Transplant: Monosegment Hepatectomy in Small Baby Recipients
Malignancies Clinical trials: A to Z 09.15-09.40
08.45-08.55 Discussion 09.00-09.20 08.55-09.35 Mureo Kasahara, Japan
Session II EUS Innovation in Hepatobiliary Disorders Diana A. Payawal, Philippines
09.40-10.00
Chairman :Kazuo Hara, Japan Anna Lok, USA
08.55-10.00 Discussion
Co-Chair: M. Begawan Bestari, Indonesia Sample size and data analyses in RCTs
Discussion
09.20-09.40 09.35-10.00
Welcome Speech & Opening Remarks Grace Wong, Hong Kong
08.55-09.00
Kazuo Hara, Japan
Moving towards the diagnostic scene in Liver Biopsy: FNA vs. FNB
09.00-09.15
Lawrence Ho Khek Yu, Singapore (Webcam)
Intraductal Ultrasound in Biliary Malignancy
09.15-09.30
Murdani Abdullah, Indonesia
Impact of EUS in Gallbladder Drainage in Clinical Pratice
09.30-09.45
C. Rinaldi A. Lesmana, Indonesia
Current Status EUS-guided Biliary Drainage for Benign and Malignant Biliary Obstruction
09.45-10.00
Kazuo Hara, Japan
10.00-10.10 Discussion
10.10-10.30 Coffee Break (Inside The Room) 10.00-10.30 Coffee Break (Inside the Room) 10.00-10.30 COFFEE BREAK (Inside The Room) 10.00-10.30 Coffee Break (Uluwatu Lobby)
10.30-12.00 Phantom Hands-on Workshop 10.30-12.00 Phantom Hands-on workshop (RFA) 10.30-10.55 Getting Funding for Studies : Industry Sponsored and Investigator-Initiated Trials 10.30-12.00 WS 5 - Session I - Post Graduate Course - Nusa Dua Hall 4
All Faculties All Faculties Rajender Reddy, USA All about Portal Hypertension
Chairman : Laurentius A. Lesmana, Indonesia
10.55-11.20 Preparing Your Abstract Co Chair : Saeed Hamid, Pakistan
Jasmohan Bajaj, USA 10.30-10.50 Hepatic Fibrosis and Development of Portal Hypertension
11.20-11.45 Giving an Effective Presentation Jordy Gracia-Sancho, Spain
W. Ray Kim, USA 10.50-11.10 Non Cirrhotic Portal Hypertension : Pathophysiology and Diagnostic Approach
11.45-12.10 Getting Your Manuscript Published Guadalupe Garcia Tsao, USA
Guadalupe Garcia Tsao, USA 10.55-11.10 Management of Non Cirrhotic Portal hypertension and Portal Biliopathy
Saeed Hamid, Pakistan
11.10-11.30 Non Invasive Assesment of Subclinical and Clinical Portal Hypertension
Laurent Castera, France

11.30-11.50 Spontaneus Porto-Systemic Shunts, Diagnostic, Clinical, Relevance, and Management

Hitoshi Maruyama, Japan

12.00-13.00 LUNCH 12.00-13.00 LUNCH 12.10-12.40 LUNCH 12.00-13.00 LUNCH

Session II - Post Graduate Course - Nusa Dua Hall 4
12.40-13.30 POSTER VIEWING - All Faculties Chairman : Laurent Castera, France
13.00-15.00
13.30-15.30 Oral Abstract Presentation Co Chair : C. Rinaldi A. Lesmana, Indonesia

Panelist 13.00-13.20 Portal Hypertension in Children : Diagnosis and Management

Panel Session: Life as an academic Hepatologist
15.30-15.55
Panelist Rajeev Khanna, India
Closing/Awarding 13.20-13.40 Primary Prohylaxis Variceal Bleeding in Child C Cirrhosis
15.55-16.00
W. Ray Kim, USA & Kemal Fariz Kalista, Indonesia Zaigham Abbas, Pakistan
13.40-14.00 Acute Variceal Bleeding Management : Beyond Guideline
Guadalupe Garcia Tsao, USA
14.00-14.20 Approach to Prevent and Reverse Cirrhotic Cardiomyopathy
Vincent Ho, Australia
Advance Therapeutic Option in Portal Hypertension : Beyond Beta Blocker
14.20-14.40
Lianda Siregar, Indonesia
14.40-15.00 Finding the Bridge Between EUS and Liver Disease: Ready for Prime Time?
C. Rinaldi A. Lesmana, Indonesia
15.00-15.30 Coffee Break
Session III - Nusa Dua Hall 4
Chairman: Guadalupe Garcia Tsao, USA
15.30-16.30
Co-Chair: Hitoshi Maruyama, Japan

15.30-15.50 Cutting-edge of Endoscopic Management in Nonalcoholic Fatty Liver Disease (NAFLD)

D. Nageshwar Reddy, India
15.50-16.10 Liver Transplantation in Portal Vein Thrombosis : Is Still Contraindication?
Masatoshi Makuuchi, Japan
16.10-16.30 Wrap up & Clossing
C. Rinaldi A. Lesmana, Indonesia
18.30-20.00 FACULTY DINNER (TEMPLE GARDEN WESTIN)
Thursday, 5 March 2020

07.00-16.00 Re-registration & On site Including Morning Coffee Break (Jimbaran Lobby)
Symposium 1 - Nusa Dua Hall 1,2,3 Symposium 2 - Nusa Dua Hall 4
07.30-09.00 07.30-09.00
Clinical Dilemma in Hepatitis B Virus Infection and Liver Transplantation Autoimmune Liver Diseases: An Update
Chairman: A. Kadir Dokmeci
Chairman: W. Ray Kim, USA (email) Co-Chair : Ignatia Sinta Murti,
Co-Chair : Poernomo Boedi Setiawan, Indonesia Indonesia

Treatment Strategy for HBeAg Positive Normal ALT Patients With Minimal or No Fibrosis Management of Severe Forms of AIH and With or Without Cirrhosis
07.30-07.50 07.30-07.55
Poernomo Boedi Setiawan, Indonesia C. Rinaldi A. Lesmana, Indonesia

Long Term Oral Antiviral Therapy Outcome in Decompensated Cirrhosis With or Without CKD Algorithmic Approach Management of PSC and It's Complications
07.50-08.10 07.55-08.20
Anna Lok, USA Ulrich H Beuers, The Netherlands
Steatosis and Liver Transplantation Outcome: Current Knowledge and Limitation PBC: Management of UDCA Refractory PBC
08.10-08.30 08.20-08.45
Adianto Nugroho, Indonesia Saut Horas Nababan, Indonesia

Precision Treatment of HBV Infection 08.45-09.00 Discussion

08.30-08.50
IDN Wibawa, Indonesia
08.45-09.00
Discussion
Presidential Lecture - Nusa Dua Hall 5
Chairman : Osamu Yokosuka, Japan & Co-Chair: Lianda Siregar, Indonesia
09.00-09.30
New Insight of Bacterial Management in Liver Cirrhosis
Laurentius A. Lesmana, Indonesia

Opening Ceremony & Award Lecture

09.30-12.15
(Nusa Dua Hall 5)

LUNCH
12.15-13.00 (Singaraja Halls)

Industrial Symposium 1- Nusa Dua Hall 1,2,3 (EISAI)

13.00-14.10
A New Horizon in The Clinical Management of Unresectable Hepatocellular Carcinoma

Opening and Welcome

13.00-13.05 Chairman: Irsan Hasan, Indonesia
Co-Chair: Lianda Siregar, Indonesia
Update in Clinical Management of Unresectable Hepatocellular Carcinoma: What's New?
13.05-13.25
Lianda Siregar, Indonesia
Addresing the Unmet Medical Needs in Unresectable Hepatocellular Carcinoma - Lenvatinib Data Review
13.25-13.50
C. Rinaldi A. Lesmana, Indonesia
Role of Lenvatinib For Unresectable Hepatocellular Carcinoma: Case Sharing
13.50-14.15
Rino A. Gani, Indonesia
Discussion and Q n A
14.15-14.25
All Participant

14.25-14.30 Summary and Closing

Irsan Hasan, Indonesia

State of The Art Lecture 1 - Nusa Dua Hall 5

Chairman: A. Kadir Dokmeci, Turkey (Canceled)
14.30-15.00 Co-Chair : M. Julwan Pribadi, Indonesia
Liver Transplantation for Small HCC: Where Do We Stand?
Toar J. M Lalisang, Indonesia

Special Interest Group 1 - Nusa Dua Hall 4 Symposium 3 - Nusa Dua Hall 5

15.00-16.30 Palliative Care in Hepato-Pancreato Biliary Disorders 15.00-16.30 Clinical Dilemma and Innovation in HCC Therapy

Chairman : Hasmik Ghazinyan, Armenia Chairman: Sahat Matondang, Indonesia

Co Chair : Arles, Indonesia Co-Chair : Sri Inggriani, Indonesia

Palliative and Supportive Care for Patients with End-Stage Liver Disease Microwave Ablation vs RFA
15.00-15.20 15.00-15.20
Diana A. Payawal, Phillipines Shuichiro Shiina, Japan
Palliative Endoscopic Management in Advance Biliary Cancer SBRT alone or as Salvage Therapy for Incomplete TACE Result
15.20-15.40 15.20-15.40
D. Nageshwar Reddy, India Sahat Matondang, Indonesia
Sleep Disturbances in Patients with Decompensated Liver Cirrhosis Surgical Innovations in Intermediate and Large HCC
15.40-16.00 15.40-16.00
Manoj Kumar, India Masatoshi Makuuchi, Japan

Pain Management in Advanced Liver Cancer RFA for Metastatic Liver Disease: Impact on Patient's Outcome
16.00-16.20 16.00-16.20
Dwi Pantja Wibowo, Indonesia Shi-Ming Lin, Taiwan
16.20-16.30 Discussion 16.20-16.30 Discussion

16.30-16.50 Coffee Break (Inside The Room)

Symposium 4 - Nusa Dua Hall 4
Coagulation Disorders and Hypersplenism and in Liver Disease Symposium 5 - Nusa Dua Hall 5
Ultrasound Innovation and Cutting Edge in HCC
16.50-18.20 16.50-18.20
Chairman : Norifumi Kawada, Japan Chairman : Hitoshi Maruyama, Japan
Co-Chair : F. Soemanto Padmomartono, Indonesia Co-Chair : Imelda M. Loho, Indonesia
Diagnostic approach and stratification management of coagulation disorders in liver cirrhosis
W. Ray Kim, USA How to Evaluate Chronic Liver Disease Based on Ultrasound Diagnosis
16.50-17.10 16.50-17.10
Andri Sanityoso Sulaiman, Indonesia
Safety issue on long-term oral anti-platelet or anticoagulant therapy in liver cirrhosis patients The Role of CEUS for Liver Cancer Screening and Evaluation
17.10-17.30 Lugyanti Sukrisman, Indonesia 17.10-17.30 Hitoshi Maruyama, Japan

Splenectomy in Liver Cirrhosis Patients With Hypersplenism and Splenomegaly The Role of RFA in Intermediate Stage of HCC
17.30-17.50 17.30-17.50
Adianto Nugroho, Indonesia Shi-Ming Lin, Taiwan
Liver Transplantation in Liver Cirrhosis Patients with Hypersplenism and Severe Pancytopenia Innovation of Fusion Ultrasound in Managing Liver Cancer
17.50-18.10 Masatoshi Makuuchi, Japan 17.50-18.10
Rino A. Gani, Indonesia

18.10-18.20 Discussion 18.10-18.20 Discussion

18.30-20.00 Sponsored Dinner Symposium by Minophagen - Dexa Medica

SPONSORED DINNER SYMPOSIUM (Minophagen-Dexa Medica) - MAIN TOPIC -

18.30-20.00
Friday, 6 March 2020

08.00-17.00 Re-registration & On site

Symposium 6 - Nusa Dua Hall 1,2,3 Symposium 7 - Nusa Dua Hall 4 Symposium 8 - Nusa Dua Hall 5
Pediatric Hepatology Perspective in NAFLD in Asia
08.00-09.30 08.00-09.30 08.00-09.30 Hepatitis Virus Infection and The Others
Chairman : Hanifah Oswari, Indonesia Chairman : Khin Maung Win, Myanmmar Chairman : Oidov Batarkhuu, Mongolia Co-
Co-Chair : Fatima Safira Alatas, Indonesia Co-Chair : Bradley Jimmy Waleleng, Indonesia Chair: Agustinus Taolin, Indonesia

Abnormal Liver Enzyme Levels in an Adolescent: What Should You Do? NAFLD in Asian countries: From Risk Factors, Pathogenesis to Clinical Manifestations HBV - HCV co infection: Viral Load and Outcome after HCV Therapy Ming
08.00-08.20 08.00-08.20 08.00-08.20
Ninung Rose, Indonesia C. Rinaldi A. Lesmana, Indonesia Lung Yu, Taiwan

Pediatric NAFLD : How to Approach? Pathological Point of View in NAFLD with Hepatitis Virus Infection Treatment Strategy in Special Population (CKD, HIV, Pregnancy)
08.20-08.40 08.20-08.40 08.20-08.40
Fatima Safira Alatas, Indonesia Marini Stephanie, Indonesia CJ Liu, Taiwan
Referring Patients for Liver Transplantation : Indication, Timing, and The Preparation to
Management Strategy for NAFLD/NASH: Asian's Perspective The Role of Gut-dysbiosis in Chronic Hepatitis C Virus Infection
08.40-09.00 Transplantation 08.40-09.00 08.40-09.00
Hanifah Oswari, Indonesia Hery Djagat Purnomo, Indonesia Yasuhito Tanaka, Japan
Progress Towards Elimination of HBV/HCV: The Crucial Role of Hepatologists in The
Bariatric Surgery in NAFLD: Safety and Efficay 09.00-09.20
09.00-09.20 Discussion 09.00-09.20 Public Health Approach
Errawan Wiradisuria, Indonesia

09.20-09.30 09.20-09.30 Discussion 09.20-09.30 Discussion

09.30-10.00 Coffee Break (Inside The Room)

Symposium 9 - Nusa Dua Hall 4
Special Interest Group 3 - Nusa Dua Hall 1,2,3 New Issues on Hepatocellular Carcinoma
Liver Fibrosis
10.00-11.30 10.00-11.30 Chair : Han-Chieh Lin, Taiwan

Chairman: Hasan Ozkan, Turkey Co-Chair : Bogi Pratomo Wibowo, Indonesia

Co-Chair: IDN Wibawa, Indonesia

Algorithmic Approach for Diagnostic of F2 and F3 Fibrosis Using Non-Invasive Test New Paradigm on Hepatocellular Carcinoma in NAFLD
10.00-10.25 10.00-10.20
Laurent Castera, France Irsan Hasan, Indonesia
Innovation Imaging to Assess Liver Fibrosis: Focus on MR-Elastography Resection and Liver Transplantation : APASL HCC Guideline
10.25-10.50 10.20-10.40
Sri Inggriani, Indonesia Kiyoshi Hasegawa, Japan

10.50-11.15 Treatment in Liver Fibrosis : How Far We Have Achieved and Its Outcome 10.40-11.00 HCC Risk in HBV Patients with Metabolic Comorbidity
Kemal Fariz Kalista, Indonesia Han-Chieh Lin, Taiwan

Controversial Issue in Stopping Nucleos(t)ide Analogs in HbeAg Negative Patients

11.15-11.30 Discussion 11.00-11.20
Jia-Horng Kao, Taiwan

11.20-11.30 Discussion

State of The Art Lecture 2 - Nusa Dua Hall 1,2,3

Chairman: A. Kadir Dokmeci, Turkey
11.30-12.00 Co-Chair : Triyanta Yuli Pramana, Indonesia
Controversies and New Perspectives in Occult Hepatitis B Infection
Anna Lok, USA

12.00-13.30 Friday Prayer (Kintamani Hall 1) & Lunch (Singaraja Halls)

Symposium 10 - Nusa Dua Hall 1,2,3 Symposium 11 - Nusa Dua Hall 4

General Hepatology Update Symposium Update on Biliary Diseases
13.30-15.00 13.30-15.00 Chairman: Zaigham Abbas, Pakistan
Chairman: Edward Gane, New Zealand
Co-Chair: Igor Vladimirovich Malov, Russia Co-Chair : Ruswhandi, Indonesia
Imaging Innovation in Biliary Diseases
Acute Hepatitis A Infection: Outbreak and Impact on Vaccination
13.30-13.55 13.30-13.50
Irsan Hasan, Indonesia Sahat B.R.E Matondang, Indonesia
Update on the Management of Hepatitis Delta Infection Controversial Issue on Endoscopic Management in Malignant Biliary Obstruction
13.55-14.20 13.50-14.10
Aghayeva Gulnara, Azerbaijan Kazuo Hara, Japan
Acute Hepatitis C infection: Management in the era of DAA Molecular Pathology of Biliary Tract Cancer
14.20-14.45 14.10-14.30
Chen-Hua Liu, Taiwan Ening Krisnuhoni, Indonesia
Surgical Management in Hepato-Cholangiocarcinoma
14.45-15.00 14.30-14.50
Discussion Wifanto S. Jeo, Indonesia

14.50-15.00 Discussion

18.00-20.00 Faculty Dinner (Negara Room, Grand Hyatt Hotel)

Saturday, 7 March 2020

08.00-17.00 Re-registration & On site

Symposium 12 - Nusa Dua Hall 1,2,3 Symposium 13 - Nusa Dua Hall 4 Symposium 14 - Nusa Dua Hall 5
Presidential Plenary (Best Abstract) Critical Care in Hepatology Update on HCC
07.50-09.30 Chairman : Ulrich H. Beuers, The Netherlands 08.00-09.30 Chairman: Saeed Hamid, Pakistan 08.00-09.30 Chairman: TC Tseng, Taiwan
Co-Chair : Putut Bayupurnama, Indonesia Co-Chair : Irsan Hasan, Indonesia
Co-Chair :David H. Muljono, Indonesia
07.50-08.00 Hepatitis Virus Infection and Its Impact on DILI HBc Antigen and The Risk of HCC
08.00-08.20 08.00-08.25
08.00-08.10 Chyntia O.M Jasirwan, Indonesia TC Tseng, Taiwan
08.10-08.20 Respiratory Failure in Liver Cirrhosis Variant HCCs, Diagnosis and Clinical Consequences
08.20-08.40 08.25-08.50
08.20-08.30 Martin Rumende, Indonesia Ening Krisnuhoni, Indonesia
08.30-08.40 Precaution and Assessment for DILI Prevention from Tuberculosis Drugs Stratification for Prediction in Patient's Outcome After Loco-Regional Therapy
08.40-09.00 08.50-09.15
08.40-08.50 Andri Sanityoso, Sulaiman, Indonesia TC Tseng, Taiwan
08.50-09.00 Fungal Infection Management in Liver Cirrhosis
09.00-09.20 09.15-09.30 Discussion
09.00-09.10 Rino A. Gani, Indonesia
09.10-09.20
09.20-09.30 Discussion
09.20-09.30
09.30-10.00 Symposium 16 - Nusa Dua Hall 4Coffee Break (Inside The Room)
Symposium 15 - Nusa Dua Hall 1,2,3 Symposium 17 - Nusa Dua Hall 5
Liver Cirrhosis: New Issue on Management Women in Hepatology Stem Cell in Liver Diseases
10.00-11.30 10.00-11.30 10.00-11.30
Chairman : Rajender Reddy, USA Chairman : Rosmawati Mohammed, Malaysia Chairman : Ian Homer Y. Cua, Philippines
Co-Chair : Fauzi Yusuf, Indonesia Co Chair : Fardah Akil, Indonesia Co-Chair : Paulus Kusnanto, Indonesia
Sarcopenia in Liver Cirrhosis : Update in Pathogenesis and Management Woman and Alcoholic Liver Disease Hepatobiliary Stem Cells : Facts and Fancies
10.00-10.25 10.00-10.20 10.00-10.25
Rajender Reddy, USA Fardah Akil, Indonesia Chyntia O.M Jasirwan, Indonesia
MHE: Treat or Not Fatty Liver in Pregnancy : Approach and Management Current Perspective Regarding Stem Cells Based Therapy for non-viral Liver Disease
10.25-10.50 10.20-10.40 10.25-10.50
Barjesh C. Sharma, India Grace Wong, Hongkong Jeanne Adiwinata Pawitan, Indonesia
Gut-Microbiota in Liver Cirrhosis: All or None Acute Liver Failure in Pregnancy: How Much Is Pregnancy‐Related? Safety Issue in Stem Cell Therapy
10.50-11.15 10.40-11.00 10.50-11.15
Jasmohan Bajaj, USA Tan Soek-Siam, Malaysia Cosphiadi Irawaan, Indonesia
Chronic Hepatitis B Virus Infection in Pregnancy
11.15-11.30 Discussion 11.00-11.20 11.15-11.30 Discussion
Rosmawati Mohamed, Malaysia
Discussion
11.20-11.30

LUNCH (Singaraja Halls)

11.30-12.30
Industrial Symposium 2 (by Mylan) - Nusa Dua Hall 1,2,3
Chronic Hepatitis B Management – Evolving Concepts and Practice Essentials
12.30-14.00
Chairman: Khin Maung Win, Myanmar
Co-Chair : Rino A. Gani, Indonesia

Immunotolerant Phase in Chronic Hepatitis B: Should We Treat?

12.30-12.50
C. Rinaldi A. Lesmana, Indonesia

Tenofovir Alafenamide in The Management of CHB: Time to Switch?

12.50-13.10 Akash Shukla, India (canceled)

Current Barriers to Hepatitis B Management-Asia Perspective

13.10-13.30
Rosmawati Mohamed, Malaysia

Asian Consensus Recommendations on Optimizing the Diagnosis and Initiation of Treatment of Hepatitis B Virus Infection in Resource-Limited Settings
13.30-13.50
Edward Gane, Australia

13.50-14.00 Panel Discussion: Strategies to Increase Treatment Rate for Chronic Hepatitis B in South-East Asia
Symposium 18 - Nusa Dua Hall 1,2,3 Symposium 19 - Nusa Dua Hall 4 APASL-EASL Joint Meeting - Uluwatu Hall 7
NAFLD and Other Related Problem Infection in Hepatobilliary Diseases Managing Complication of Liver Disease
14.00-15.30 14.00-15.30 14.00-15.30
Chairman: Iswan A. Nusi, Indonesia Chairman: Ian Homer Y. Cua, Phillipines Chairman :Laurentius A. Lesmana, Indonesia
Co-Chair : C. Rinaldi A. Lesmana, Indonesia Co-Chair: F. X. Pridady, Indonesia Co-Chair : Ulrich H. Beuers, The Netherlands
Update Pathophysiology Concept Related to Other Metabolic Parameters Tropical infection and Liver Toxicity Diagnosis of Cirrhosis and Portal Hypertension: Non Invasive or Invasive Test?
14.00-14.20 14.00-14.25 14.00-14.25
Hery Djagat Purnomo, Indonesia Saut Horas Nababan, Indonesia Gamal Shiha, Egypt
The Role of Gut Dysbiosis and Its Impact on Management
14.20-14.40 14.25-14.50 Update Management in Pyogenic Liver Abscess 14.25-14.50 Bleeding and Thrombosis in End Stage Liver Disease
Jasmohan Bajaj, USA Juferdy Kurniawan, Indonesia Cosphiadi Irawan, Indonesia
14.40-15.00 NAFLD and Coronary Arterial Disease 14.50-15.15 Biliary Sepsis Management: Percutaneous, Endoscopic, or Surgical 14.50-15.15 Management of Cholestatic Diseases and It's Complications
Chan Wah Keong, Malaysia Necati Ormeci, Turkey Ulrich H. Beuers, The Netherlands
15.00-15.20 NAFLD and Non Alcoholic Fatty Pancreas Diseases : Together in Line? 15.15-15.30 Discussion
15.15-15.30 Discussion
C. Rinaldi A. Lesmana, Indonesia
15.20-15.30 Discussion

15.30-15.50 Coffee Break (Inside The Room)

Symposium 20 - Nusa Dua Hall 1,2,3 Heart and Symposium 21- Nusa Dua Hall 4 Symposium 22 - Uluwatu Hall 7
15.50-17.20 15.50-17.20 15.50-17.20
Liver Lung and Liver Regression of Fibrosis and Portal Hypertension in CLD: Is It Really Feasible?

Chairman: Gontar A. Siregar, Indonesia Chairman : Aghayeva Gulnara, Azerbaijan Chairman : Norifumi Kawada, Japan
Co-Chair : Riki Tenggara, Indonesia Co-Chair : Ummi Maimunah, Indonesia Co-Chair : Jordi Gracia-Sancho, Spain
15.50-16.15 Cardiohepatic Disfunction: Interaction Pathogenesis and Clinical Manifestation 15.50-16.10 Hepatopulmonary Syndrome: Update on Pathogenesis and Clinical Pictures 15.50-16.10 Regression of Portal Hypertension - Mechanisms & New Therapeutics
Sally Aman Nasution, Indonesia Lianda Siregar, Indonesia Jordi Gracia-Sancho, Spain
16.15-16.40 Myorcardal dysfunction Associated with Hepatitis B Virus Infection 16.10-16.30 Update on Medical Treatment for the Hepatopulmonary Syndrome 16.10-16.30 Regression of Fibrosis - Current Evidence & Future Perspectives
Ian Homer Y. Cua, Philippines Ignatia Sinta Murti, Indonesia Norifumi Kawada, Japan
16.40-17.05 NAFLD and The Heart 16.30-16.50 The Impact of Liver Transplantation in the Patients with Hepatopulmonary Syndrome 16.30-16.50 Regression of Portal Hypertension & Fibrosis: Viral Hepatitis
Irsan Hasan, Indonesia Vincent Ho, Australia Gamal Shiha, Egypt
16.50-17.10 Personalizing Care in Patients with Liver Cirrhosis 16.50-17.10 Regression of Portal Hypertension & Fibrosis: Non-Viral Cirrhosis
17.05-17.20 Discussion
Aghayeva Gulnara, Azerbaijan Saut Nababan, Indonesia
Non-Invasive Assesment of Portal Hypertension & Fibrosis Regression
17.10-17.20 Discussion 17.10-17.20
Kemal Fariz Kalista, Indonesia
17.20-17.30 Discussion

18.00-20.00 GALA DINNER, AWARD PRESENTATION & CLOSING CEREMONY (Nusa Dua Hall 5)